These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 1688031

  • 1. The peptide VIP is a neurotransmitter in rat adrenal medulla: physiological role in controlling catecholamine secretion.
    Wakade TD, Blank MA, Malhotra RK, Pourcho R, Wakade AR.
    J Physiol; 1991 Dec; 444():349-62. PubMed ID: 1688031
    [Abstract] [Full Text] [Related]

  • 2. Cross-communication between acetylcholine and VIP in controlling catecholamine secretion by affecting cAMP, inositol triphosphate, protein kinase C, and calcium in rat adrenal medulla.
    Malhotra RK, Wakade TD, Wakade AR.
    J Neurosci; 1989 Dec; 9(12):4150-7. PubMed ID: 2556506
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal polypeptide stimulates the secretion of catecholamines from the rat adrenal gland.
    Malhotra RK, Wakade AR.
    J Physiol; 1987 Jul; 388():285-94. PubMed ID: 3656194
    [Abstract] [Full Text] [Related]

  • 4. Noncholinergic transmitter(s) maintains secretion of catecholamines from rat adrenal medulla for several hours of continuous stimulation of splanchnic neurons.
    Wakade AR.
    J Neurochem; 1988 Apr; 50(4):1302-8. PubMed ID: 2894411
    [Abstract] [Full Text] [Related]

  • 5. Effects of vasoactive intestinal polypeptide antagonists on cholinergic neurotransmission in dog and cat trachea.
    Xie ZQ, Hirose T, Hakoda H, Ito Y.
    Br J Pharmacol; 1991 Dec; 104(4):938-44. PubMed ID: 1667294
    [Abstract] [Full Text] [Related]

  • 6. Non-cholinergic component of rat splanchnic nerves predominates at low neuronal activity and is eliminated by naloxone.
    Malhotra RK, Wakade AR.
    J Physiol; 1987 Feb; 383():639-52. PubMed ID: 3656137
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal polypeptide and muscarine mobilize intracellular Ca2+ through breakdown of phosphoinositides to induce catecholamine secretion. Role of IP3 in exocytosis.
    Malhotra RK, Wakade TD, Wakade AR.
    J Biol Chem; 1988 Feb 15; 263(5):2123-6. PubMed ID: 3123488
    [Abstract] [Full Text] [Related]

  • 8. Modulation of cholinergic neurotransmission by the peptide VIP, VIP antiserum and VIP antagonists in dog and cat trachea.
    Hakoda H, Ito Y.
    J Physiol; 1990 Sep 15; 428():133-54. PubMed ID: 2172520
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fetal adrenal VIP: distribution and effect on medullary catecholamine secretion.
    Cheung CY, Holzwarth MA.
    Peptides; 1986 Sep 15; 7(3):413-8. PubMed ID: 3534807
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous secretion of catecholamines from the adrenal medulla and of [3H]norepinephrine from sympathetic nerves from a single test preparation: different effects of agents on the secretion.
    Wakade AR, Malhotra RK, Wakade TD, Dixon WR.
    Neuroscience; 1986 Aug 15; 18(4):877-88. PubMed ID: 3762930
    [Abstract] [Full Text] [Related]

  • 12. Effects of desipramine, trifluoperazine and other inhibitors of calmodulin on the secretion of catecholamines from the adrenal medulla and postganglionic sympathetic nerves of the salivary gland.
    Wakade AR, Wakade TD.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr 15; 325(4):320-7. PubMed ID: 6728041
    [Abstract] [Full Text] [Related]

  • 13. Differential secretion of catecholamines in response to peptidergic and cholinergic transmitters in rat adrenals.
    Guo X, Wakade AR.
    J Physiol; 1994 Mar 15; 475(3):539-45. PubMed ID: 8006835
    [Abstract] [Full Text] [Related]

  • 14. Correlation between neural release of VIP and adrenomedullary catecholamine secretion in vivo.
    Gaspo R, Yamaguchi N, de Champlain J.
    Am J Physiol; 1995 Jun 15; 268(6 Pt 2):R1449-55. PubMed ID: 7611521
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of antagonists of vasoactive intestinal peptide on nonadrenergic noncholinergic inhibitory responses in feline airways.
    Thompson DC, Altiere RJ, Diamond L.
    Peptides; 1988 Jun 15; 9(2):443-7. PubMed ID: 3131749
    [Abstract] [Full Text] [Related]

  • 17. Localization and release of immunoreactive vasoactive intestinal polypeptide in bovine adrenal medulla.
    Yoshikawa M, Saito H, Sano T, Ohuchi T, Ishimura Y, Morita K, Saito S, Oka M.
    Neurosci Lett; 1990 Mar 26; 111(1-2):75-9. PubMed ID: 2336195
    [Abstract] [Full Text] [Related]

  • 18. Facilitation of secretion of catecholamines from rat and guinea-pig adrenal glands in potassium-free medium or after ouabain.
    Wakade AR.
    J Physiol; 1981 Mar 26; 313():481-98. PubMed ID: 7277231
    [Abstract] [Full Text] [Related]

  • 19. Contribution of nicotinic and muscarinic receptors in the secretion of catecholamines evoked by endogenous and exogenous acetylcholine.
    Wakade AR, Wakade TD.
    Neuroscience; 1983 Nov 26; 10(3):973-8. PubMed ID: 6139771
    [Abstract] [Full Text] [Related]

  • 20. Contribution of SK and BK channels in the control of catecholamine release by electrical stimulation of the cat adrenal gland.
    Montiel C, López MG, Sánchez-García P, Maroto R, Zapater P, García AG.
    J Physiol; 1995 Jul 15; 486 ( Pt 2)(Pt 2):427-37. PubMed ID: 7473208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.